ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619031 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619031; 2) Community: the network communities that were significantly associated with the response to NSC 619031; 3) Molecule: the relationships between components within communities and NSC 619031; 4) MDR: the compounds that were significantly associated with the NSC 619031.

NSC Compound Enrichment Correlation
NSC 615291 Bizelesin 0.0105244982742819 0.72717325
NSC 619030 Analog of CC-1065 0.0105244982742819 0.9548972
NSC 669146 6,9-Epoxy-2H-1,4-dioxacyclodeca[cd]pentalene-2,7(4aH)-dione, 2a,3,5,6,11a,11b-hexahydro-3-hydroxy-2a,6,10-trimethyl-3-(1-methylethenyl)-, [2aS-(2aR*,3S*,4aR*,6S*,10Z,11aS*,11bS*)]- 0.0105244982742819 -0.070603768
NSC 642324 Null 0.0105244982742821 0.5890063
NSC 672974 Null 0.0105244982742821 0.52106579
NSC 674182 Null 0.0105244982742821 0.61559811
NSC 681633 Camptothecin Derivative 0.0105244982742821 0.79154869
NSC 700363 Liposomal Annamycin 0.0105244982742821 0.62937802
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0105244982742821 0.74263113
NSC 681640 Camptothecin Derivative 0.0105607789694647 0.78046819
Total:40  Current:11    [First] [Prev] [Next] [Last]